11.50EUR-0.69%Mkt Cap: 2.43B EURP/E: 59.58Last update: 2026-05-14
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, a…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)59.58
P/E (Forward)20.23
PEG1.00
P/B1.63
P/S2.17
EV/EBITDA12.03
EV/Revenue2.15
EPS (TTM)0.19
EPS (Forward)0.56
Cash Flow & Leverage
FCF Yield0.26%
FCF Margin0.56%
Operating CF174.46M EUR
CapEx (TTM)137.31M EUR
Net Debt/EBITDA-0.13
Net Debt-25.80M EUR
Technical
SMA 5012.14 (-5.2%)
SMA 20012.20 (-5.8%)
Beta0.20
S&P 52W Chg24.23%
Avg Vol (30d)126.60K
Avg Vol (10d)138.51K
Technical Indicators
RSI (14)29.6
MACD-0.2180
MACD Signal-0.0877
MACD Hist.-0.1302
BB Upper13.24 EUR
BB Middle12.35 EUR
BB Lower11.45 EUR
BB Width14.49%
ATR (14)0.3817 EUR
Vol Ratio (20d)1.18x
52W Range
10.0038% of range13.98
52W High13.98 EUR
52W Low10.00 EUR
Profitability
Gross Margin78.66%
EBITDA Margin17.83%
Profit Margin4.17%
Oper. Margin10.26%
ROE3.10%
ROA1.97%
Revenue Growth2.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.23
Current Ratio2.31
Quick Ratio1.57
Book Value/Sh6.924 EUR
Cash/Share1.449 EUR
Dividends
Fwd Div Rate0.1900 EUR
Trail. Div Rate0.1900 EUR
Div. Yield1.65%
5Y Avg Yield1.83%
Payout Ratio96.84%
Ex-Div DateMay 14, 2026
Pay Date—
Splits
Last Split47:46
Split DateSep 14, 2020
Ownership
Shares Out.214.63M
Float75.35M
Insiders64.96%
Institutions18.41%
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)14.57 EUR
Target Range12.50 EUR – 17.50 EUR
# Analysts12
Company
Market Cap2.43B EUR
Enterprise Value2.41B EUR
Revenue (TTM)1.12B EUR
Gross Profit871.61M EUR
Net Income (TTM)46.15M EUR
Revenue/Share5.208 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.1K
Last Price11.50 EUR
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0157097017